CPA3 and asthma: Evidence of increased CPA3 and elevated urinary tetranor-PGD-M, the major urinary metabolite of mast cell prostaglandin D2 (PGD2), suggests that mast cell activation plays a pivotal role in T2-independent severe asthma [17].